Iliac Crest Bone Marrow Aspiration

Author(s):  
Shounuck I. Patel ◽  
Vishal Thakral
2014 ◽  
Vol 38 (11) ◽  
pp. 2377-2384 ◽  
Author(s):  
Jacques Hernigou ◽  
Laure Picard ◽  
Alexandra Alves ◽  
Jonathan Silvera ◽  
Yasuhiro Homma ◽  
...  

2005 ◽  
Vol 57 (suppl_4) ◽  
pp. ONS-286-ONS-289 ◽  
Author(s):  
Scott H. Kitchel ◽  
Michael Y. Wang ◽  
Carl L. Lauryssen

Abstract OBJECTIVE: The osteogenicity of bone marrow has been well documented in the literature. The use of bone marrow as a source of osteoprogenitor cells for spinal fusion surgery is increasing. Improper aspiration technique can lead to dilution of bone marrow and a subsequent reduction in osteoprogenitor cells. Therefore, correct aspiration technique is imperative to the successful use of bone marrow with various grafting combinations. METHODS: The authors describe techniques for aspirating bone marrow from the anterior and posterior iliac crest, as well as vertebral body aspiration. The use of selective cell retention to increase the number of osteoprogenitor cells populating a graft is also described. RESULTS: Complications from bone marrow aspiration can occur, but the incidence is rare. CONCLUSION: Clinical studies currently under way will answer the question of bone marrow efficacy in spinal fusion surgery.


Author(s):  
Ryan S. D'Souza ◽  
Langping Li ◽  
Shuai Leng ◽  
Christine Hunt ◽  
Luke Law ◽  
...  

Bone marrow aspiration (BMA) through the iliac crest is potentially unsafe due to the vicinity of neurovascular structures in the greater sciatic notch. Our objective was to investigate the safety of a recently described BMA technique, specifically a trajectory from the posterior superior iliac spine (PSIS) to the anterior inferior iliac spine (AIIS). We conducted a chart review of 260 patients, analyzing three-dimensional reconstructed computed tomography images of the pelvis and sacrum to validate that this new approach offers a wide safety margin from the greater sciatic notch. Analysis of three-dimensional computed tomography scans demonstrated that the PSIS to AIIS trajectory never crossed the greater sciatic notch. The trajectory was noted to be at least one cm away from the greater sciatic notch in all measurements. The new trajectory entered the PSIS at 25.29 ± 4.34° (left side) and 24.93 ± 4.15° (right side) cephalad from the transverse plane, and 24.58 ± 4.99° (left side) and 24.56 ± 4.67° (right side) lateral from the mid-sagittal plane. The area of bone marrow encountered with the new approach was approximately 22.5 cm2. Utilizing the same CT scans, the trajectory from the traditional approach crossed the greater sciatic notch in all scans, highlighting the potential for violating the greater sciatic notch boundary and damaging important neurovascular structures. Statistically significant sex-related differences were identified in needle trajectory angles for both approaches. We conclude that based on this three-dimensional computed tomography study, a trajectory from the PSIS to the AIIS for BMA may offer a wide safety margin from the greater sciatic notch.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 4548-4548
Author(s):  
Enrique Davila

Abstract Abstract 4548 The aspiration and biopsy of the bone marrow is one of the most valuable and important tests in hematology, oncology and medicine. It is a high yield, safe, fast and informative test performed frequently in medical practice with minimal complications. For reasons of ease and safety, bone marrow aspiration and biopsy are usually obtained from the posterior iliac crest. I reviewed my experience in obtaining 37 consecutive bone marrow biopsies from the sternum using a Jamshidi needle (gauge 11; external diameter 3.048 mm) in 36 consecutive patients (twice in one patient) over a 9 year period, in whom a posterior iliac crest study could not be done. Technique After performing the sternal bone marrow aspiration in the usual manner, a small skin incision is made over the sternum with a scalpel. The Jamshidi needle is introduced at approximately a 90 degree angle in the middle of the sternum at the level of the 3rd intercostal space. After a ”give” is felt, indicating that the needle has reached the bone marrow cavity, the tip of the needle is angled downwards at 45 degrees or less and with a clockwise - counterclockwise movement, the needle is advanced for 3 to 10 mm. After a slight change of angle aiming at “breaking” the distal attachment of the bone marrow piece, the needle is slowly withdrawn with the same rotatory movements. In no case did I feel that I had reached the inner table of the sternum. All patients were observed and examined 20 minutes and 24 hours after the procedure. Results There were 22 inpatient and 15 outpatient procedures. The reasons that precluded the performance of the preferred posterior iliac crest bone marrow biopsy were: immobility in 17 patients, obesity in 13, prior radiation in 3 and other in 4. The final diagnosis was a malignant disorder in 17 patients (leukemia, lymphoma, myelodysplasia, plasma cell dyscrasia or metastatic cancer). All but one were new diagnoses. In 20 cases the final diagnosis was a benign hematological disorder or a non diagnostic bone marrow examination. In 9 occasions (mostly obese patients and patients with prior radiation therapy) a previous attempt at performing a posterior iliac crest biopsy had failed. The only complications were the development of a tumor nodule in the needle tract in one patient with an aggressive, Burkitt's type lymphoma and a small superficial hematoma in a patient with a highly vascular metastatic breast cancer. The bone marrow core biopsy of the sternum, performed as described, in the hands of an experienced practitioner is a safe and helpful test in the evaluation of the bone marrow cytology, architecture and anatomy in selected patients in whom the performance of the preferred posterior iliac crest biopsy cannot be done. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 4718-4718 ◽  
Author(s):  
Maria G. Falcon ◽  
Chatchawin Assanasen ◽  
Paul Thomas ◽  
Victor Saldivar

Abstract Abstract 4718 Bone marrow examination is important for the diagnosis of hematological malignancies and nonmalignant diseases in children. In patients with newly diagnosed lymphoproliferative diseases and certain non-hematopoietic malignancies, bone marrow examination is also part of the staging process. Core biopsy length has been found to be critical in diagnosing, predicting relapse or identifying residual disease following chemotherapy in patients. The larger the amount of marrow obtained increases the chance of finding a focal lesion. Unfortunately, the current practice of obtaining trephine biopsies and bone marrow aspirates in children via the manual method has a poor success rate for obtaining adequate specimens. In 2007, an FDA-cleared battery powered bone marrow aspiration and biopsy system (OnControl™ by Vidacare) was developed. Multiple studies have evaluated the use of the powered device in adults and found decreased time of procedure, decreased pain, and improved core biopsy specimens. Here we present a direct comparison of the rotary powered device versus the traditional manual device (e.g. Jamshidi) when obtaining bilateral bone marrow aspirates and biopsies in a 17 year-old female with relapsed alveolar rhabdomyosarcoma. This patient required bilateral bone marrow biopsies to stage her disease and evaluate for bone marrow involvement. One aspirate and biopsy was obtained using the powered device from the right posterior superior iliac crest, and specimens were obtained from the left iliac crest using the traditional manual device. The endpoints measured were quality of the biopsy, length and width of the biopsy, time to obtain aspirate and biopsy, number of attempts to obtain the biopsy, post-procedural pain, and operator satisfaction with the device (O.S.). Device Quality Rating Length (mm) Width (mm) Aspirate Time (sec) Biopsy Time (sec) Attempts Pain Score (0–10) O.S. (0–10) Powered 2 9 1.5 20 108 1 0 10 Manual 1 14 2 25 225 1 0 9 In conclusion, the powered device was superior to the manual device in terms of time to obtain the aspirate and biopsy and operator satisfaction with the device. It was found to be equivalent to the manual device in regards to number of attempts to obtain the biopsy, and post-procedural pain score. The manual device produced a biopsy that was longer, wider, and of higher quality than the biopsy obtained via the powered method. A randomized controlled trial in the pediatric population comparing the rotary powered device to the traditional device is currently underway as further studies are needed to evaluate the use of the powered bone marrow aspiration and biopsy device in children. Disclosures: Falcon: Vidacare Corporation: Research Funding. Assanasen:Vidacare Corporation: Research Funding.


Author(s):  
Bradly S. Goodman ◽  
Srinivas Mallempati

2017 ◽  
Vol 99A (19) ◽  
pp. 1673-1682 ◽  
Author(s):  
Thomas E. Patterson ◽  
Cynthia Boehm ◽  
Chizu Nakamoto ◽  
Richard Rozic ◽  
Esteban Walker ◽  
...  

Blood ◽  
2019 ◽  
Vol 134 (Supplement_1) ◽  
pp. 5848-5848
Author(s):  
Jennifer U Obasi ◽  
Adrian P Umpierrez De Reguero

Background: Bone marrow sampling is an invasive procedure that can be obtained by aspiration and biopsy(also called trephine biopsy) and as such, requires good technical skills to avoid complications and increase diagnostic yield. Aspirate and biopsy samples are complementary and when obtained together, are an invaluable tool toward obtaining an accurate and comprehensive profile for cellular, cytogenetic, immunophenotypic and cytological assessments. Bone marrow aspiration and trephine biopsy are generally regarded as relatively low risk procedures, however, factors that should be taken into consideration include disseminated intravascular coagulopathy, factor deficiencies, skin infections, and severe thrombocytopenia. In adults, the posterior iliac crest is often the preferred site but other accessed sites include the sternum (aspiration only) and anterior superior iliac crest in obese patients.For procedures performed at the posterior iliac spine, possible complications include pain, bleeding and infection. The hospitalist procedure service is a relatively newer advent that make up a subset of hospital medicine practice, mostly in larger academic centers. They are made up of internal medicine faculty with additional procedural training and expertise in bedside procedural care. Depending on the institution, the service performs a variety of procedures with lumbar punctures, thoracentesis and paracentesis, comprising a bulk of them. Other services include bone marrow sampling, arthrocentesis and chest tube placement. The long term impact of procedure services on inpatient hospital teams continues to be an ongoing area of research, but so far, studies have shown that these services have been associated with an increase in best practice safety process measures, increased patient satisfaction, and faster access to procedures without increasing complication rates. At our institution, this procedure is performed by hematology/oncology staff and fellows and advanced practice providers (APP) in collaboration and with direct supervision by an attending physician. Direct supervision is usually unnecessary once competency is determined. Other services qualified to provide this service at our institution include the inpatient hospitalist bedside procedure service (HBPS) and interventional radiology (particularly if needed under computed tomography (CT) guidance). Other than those performed by hematology/oncology providers, the HBPS at our institution is responsible for the majority of bone marrow aspiration and biopsies performed at the bedside. Methods: We reviewed procedure records kept by the inpatient HBPS from February 2017 through May 2019. Most bone marrow sampling were performed on patients on the adult inpatient hematology/oncology service. Other inpatient services represented included Internal Medicine, Physical Medicine and Rehabilitation (PM&R), Cardiology and Transplant (Surgical and Medical). Informed consent was obtained from all patients and/or patient surrogates. All procedures were performed at either the right or left posterior iliac crest using a powered bone marrow biopsy device (Teleflex Arrow On-Control) with an 11 gauge bone access needle, either 4 or 6 inches in length. The site was obtained via landmarks with the patient in either the prone or lateral decubitus position. Specific orders for the procedure were placed by the inpatient clinician/practitioner requesting the procedure. A technician was present at bedside to prepare slides. Results: Of the 233 patients on which bone marrow aspirates and/or biopsies were attempted, 217 (93%) were performed successfully. 16 (7%) were unsuccessful with those patients subsequently referred to interventional radiology for placement under CT guidance. Of the procedures which were successful, 181 (83.4%) were successful with the first attempt, while 36 (16.6%) required more than one attempt. 1 (0.4%) patient experienced a procedural complication secondary to a hematoma. Conclusions: We propose that bone marrow sampling performed by a hospitalist procedure services is a safe and efficacious option and alternative for busy inpatient hematology/oncology services as it can provide faster access to care for patients who need the procedure. It also helps liberate hematology/oncology providers from performing these procedures to allow them the opportunity to focus on patient care and rounds. Disclosures No relevant conflicts of interest to declare.


2012 ◽  
Vol 15 (2) ◽  
pp. 116 ◽  
Author(s):  
Ali Ghodsizad ◽  
Viktor Bordel ◽  
Brian Bruckner ◽  
Mathias Loebe ◽  
Gunter Fuerst ◽  
...  

The application of somatic stem cells has been shown to support the recovery of the myocardium in end-stage heart failure. A novel method for the intraoperative isolation and labeling of bone marrow-derived stem cells was established. After induction of general anesthesia, up to 400 mL of bone marrow were harvested from the posterior iliac crest and processed in the operating room under good manufacturing practice conditions by means of the automated cell-selection device Clini-MACS (Miltenyi Biotec). We subsequently injected autologous CD133<sup>+</sup> and CD34<sup>+</sup> stem cells in a predefined pattern around the laser channels in patients undergoing coronary artery bypass surgery and transmyocardial laser procedures. Intraoperative isolation and labeling is an effective cell-separation tool for the future, considering that novel cell markers can be promising new candidates for cell therapy.


Sign in / Sign up

Export Citation Format

Share Document